Patients who have surgery for esophageal cancer commonly see the disease return, but a drug that boosts the immune system may help delay or prevent that, a new trial has found.
Apr 1, 2021
0
12
A new technique for sampling and testing cells from Barrett's esophagus (BE) patients could result in earlier and easier identification of patients whose disease has progressed toward cancer or whose disease is at high risk ...
Mar 22, 2021
0
5
Manar Yanes from the research group Upper GI Surgery, the Department of Molecular Medicine and Surgery, will defend his thesis "Antireflux surgery in the prevention of supra-esophageal cancer and mortality" on March 26, 2021. ...
Mar 19, 2021
0
3
Results from a large prospective study indicate that gastroesophageal reflux disease (GERD), which also causes heartburn symptoms, is linked with higher risks of various cancers of the larynx (or voice box) and esophagus. ...
Feb 22, 2021
0
3
Elderly patients (70 years and over) with locally advanced esophageal (E) and esophagogastric junction (EGJ) cancer (located in the stomach and esophagus) should be considered for optimal therapy that has the potential to ...
Feb 9, 2021
0
0
It is increasingly clear that the trillions of bacteria that make themselves at home in and on the human body are more than just casual observers along for the ride. Gut bacteria in particular have been shown to have an enormous ...
Jan 14, 2021
0
9
Esophageal adenocarcinoma is occurring more frequently in adults under age 50, and these younger adults are more likely to be diagnosed at advanced stages, according to a study published in Cancer Epidemiology, Biomarkers ...
Dec 16, 2020
0
2
A new guideline from the Canadian Task Force on Preventive Health Care, based on a rigorous systematic review of the latest evidence, found no benefit of routine screening for esophageal adenocarcinoma (EAC) and precursor ...
Jul 6, 2020
0
2
Black patients with esophageal cancer are at a higher risk of death compared to white patients. Although many reasons have been suggested for this, few have given physician actionable information. A new study from the Sidney ...
Jun 25, 2020
0
1
Results of the NRG Oncology clinical trial RTOG 1010 indicate that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival (DFS) outcomes for patient ...
Jun 1, 2020
0
0
